Wang H, Jiang X, Chan K, Wei Y, Hung C, Chan R
BMC Infect Dis. 2024; 24(1):667.
PMID: 38961350
PMC: 11223378.
DOI: 10.1186/s12879-024-09520-9.
Perez-Castro E, Guzman-Martinez M, Godinez-Jaimes F, Reyes-Carreto R, Vargas-De-Leon C, Aguirre-Salado A
Healthcare (Basel). 2024; 12(3).
PMID: 38338191
PMC: 10855302.
DOI: 10.3390/healthcare12030306.
Lushington G, Linde A, Melgarejo T
BioTech (Basel). 2023; 12(4).
PMID: 37987478
PMC: 10660736.
DOI: 10.3390/biotech12040061.
Bakakos A, Sotiropoulou Z, Vontetsianos A, Zaneli S, Papaioannou A, Bakakos P
J Asthma Allergy. 2023; 16:1025-1040.
PMID: 37791040
PMC: 10543746.
DOI: 10.2147/JAA.S277455.
Lv B, Huang S, Huang H, Niu N, Liu J
Mediators Inflamm. 2023; 2023:6685251.
PMID: 37674786
PMC: 10480029.
DOI: 10.1155/2023/6685251.
Predictors of pulmonary embolism in hospitalized patients with COVID-19.
Bahk J, Rehman A, Ho K, Narasimhan B, Baloch H, Zhang J
Thromb J. 2023; 21(1):73.
PMID: 37400813
PMC: 10316556.
DOI: 10.1186/s12959-023-00518-y.
Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance.
Beurnier A, Yordanov Y, Dechartres A, Dinh A, Debuc E, Lescure F
ERJ Open Res. 2022; 8(4).
PMID: 36284827
PMC: 9501655.
DOI: 10.1183/23120541.00012-2022.
Clinical benefits of inhaled ciclesonide for hospitalized patients with COVID-19 infection: a retrospective study.
Kuo K, Chen C, Wang C, Wu J, Chung H, Chen Y
BMC Pulm Med. 2022; 22(1):368.
PMID: 36171597
PMC: 9517967.
DOI: 10.1186/s12890-022-02168-8.
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
Papaioannou A, Fouka E, Tzanakis N, Antoniou K, Samitas K, Zervas E
J Allergy Clin Immunol Pract. 2022; 10(10):2588-2595.
PMID: 35752436
PMC: 9222651.
DOI: 10.1016/j.jaip.2022.05.041.
Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians.
Lommatzsch M, Rabe K, Taube C, Joest M, Kreuter M, Wirtz H
Respiration. 2022; 101(3):307-320.
PMID: 35231915
PMC: 8985038.
DOI: 10.1159/000518896.
The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium.
Bonser L, Eckalbar W, Rodriguez L, Shen J, Koh K, Ghias K
Am J Respir Cell Mol Biol. 2022; 66(4):391-401.
PMID: 34982656
PMC: 8990122.
DOI: 10.1165/rcmb.2021-0364OC.
Facts and Challenges about Asthma and COVID-19 among the Paediatric Population: A Systematic Literature Review.
Moreno-Sanchez E, Castillo-Viera E, Velez-Moreno E, Gago-Valiente F
Medicina (Kaunas). 2021; 57(12).
PMID: 34946251
PMC: 8706787.
DOI: 10.3390/medicina57121306.
Non-communicable diseases, sociodemographic vulnerability and the risk of mortality in hospitalised children and adolescents with COVID-19 in Brazil: a cross-sectional observational study.
Sousa B, Brentani A, Ribeiro C, Dolhnikoff M, Grisi S, Ferrer A
BMJ Open. 2021; 11(9):e050724.
PMID: 34489291
PMC: 8423513.
DOI: 10.1136/bmjopen-2021-050724.
Obesity is independently associated with septic shock, renal complications, and mortality in a multiracial patient cohort hospitalized with COVID-19.
Page-Wilson G, Arakawa R, Nemeth S, Bell F, Girvin Z, Tuohy M
PLoS One. 2021; 16(8):e0255811.
PMID: 34383798
PMC: 8360607.
DOI: 10.1371/journal.pone.0255811.
Asthma and COVID-19: a dangerous liaison?.
Lombardi C, Gani F, Berti A, Comberiati P, Peroni D, Cottini M
Asthma Res Pract. 2021; 7(1):9.
PMID: 34261543
PMC: 8279806.
DOI: 10.1186/s40733-021-00075-z.
An Overview of Asthma and COVID-19: Protective Factors Against SARS-COV-2 in Pediatric Patients.
Liuzzo Scorpo M, Ferrante G, La Grutta S
Front Pediatr. 2021; 9:661206.
PMID: 33996694
PMC: 8116485.
DOI: 10.3389/fped.2021.661206.
Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease.
Frohman E, Villemarette-Pittman N, Rodriguez A, Glanzman R, Rugheimer S, Komogortsev O
J Neurol Sci. 2021; 426:117463.
PMID: 33971376
PMC: 8055502.
DOI: 10.1016/j.jns.2021.117463.
The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium.
Bonser L, Eckalbar W, Rodriguez L, Shen J, Koh K, Zlock L
bioRxiv. 2021; .
PMID: 33655249
PMC: 7924269.
DOI: 10.1101/2021.02.25.432762.
The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection.
Ho K, Howell D, Rogers L, Narasimhan B, Verma H, Steiger D
Ann Allergy Asthma Immunol. 2021; 127(1):42-48.
PMID: 33647451
PMC: 7910126.
DOI: 10.1016/j.anai.2021.02.021.
Asthma and COVID-19: Preconceptions about Predisposition.
Beasley R, Hills T, Kearns N
Am J Respir Crit Care Med. 2021; 203(7):799-801.
PMID: 33600744
PMC: 8017587.
DOI: 10.1164/rccm.202102-0266ED.